2YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
ST33777 | ||
MAP4343 | 1-[(3S,8S,9S,10R,13R,14S,17S)-3-methoxy-10,13-dimethyl-2,3,4,7,8,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone | 511-26-2 |
1-Boc-1,8-diaminooctane | 1-叔丁氧羰基-1,8-二氨基辛烷 | 88829-82-7 |
VU 29 | VU-29 | 890764-36-0 |
GSK3987 | 化合物 T27478 | 264206-85-1 |
NPD8733 | 化合物NPD8733 | 696655-62-6 |
SKI 178 | 化合物SKI-178 | 1259484-97-3 |
Autogramin-1 | 化合物AUTOGRAMIN-1 | 2375541-73-2 |
BRD-K98645985 | BRD-K98645985 | 1357647-78-9 |
Synucleozid | NSC 377363 | 502139-01-7 |
NSC 2805 | NSC2805 | 4371-34-0 |
ElteN378 | ELTE-N378 | 1421366-99-5 |
CYD19 | 化合物 SNAIL/HDAC-IN-1 | 2415281-52-4 |
KYN-101 | ||
SSAA09E3 | 化合物SSAA09E3 | 52869-18-8 |
GSK778 | FREEBASE | 2451862-42-1 |
2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one | 化合物T8563 | 1234707-32-4 |
Miclxin | 化合物MICLXIN | 2494198-61-5 |
SHIN2 | SHMT-IN-2 | 2102681-49-0 |
ARN-21934 | ARN-21934 | 2230854-93-8 |
FPPS-IN-11 | 1250273-31-4 | |
TET-IN-C35 | ||
Comp-43 | ||
homo-vk-ii-36 | ||
Oseltamivirphosphate | 磷酸奥司他韦 | 204255-11-8 |
Benzyl Benzodithioate | 1H-吡咯-1-碳二硫代苄酯 | 60795-38-2 |
C-170 | 化合物C-170 | 346691-38-1 |
Dersimelagon | Dersimelagon | 1835256-48-8 |
MK-8722 | MK-8722 | 1394371-71-1 |
2BAct | 2BAct(eIF2B activator 2BAct) | 2143542-28-1 |
APS6-45 | 化合物APS6-45 | 2188236-41-9 |
IMM-H007 | 化合物IMM-H007 | 1221412-23-2 |
GW805758 | ||
FABP4/5-IN-2 | 1227413-92-4 | |
K-975 | K975 | 2563855-03-6 |
Phevamine A | 化合物 T34026 | 2280874-34-0 |
SIRT6 activator 12q | 2601734-99-8 | |
LONAFARNIB | 洛那法尼 | 193275-84-2 |
BIBO-3304 TFA | N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate | 191868-14-1 |
Azo-Resveratrol | Azo-Resveratrol | 1393556-48-3 |
preQ1 Dihydrochloride | Pre-queuosine1 dihydrochloride | 86694-45-3 |
BTA-EG4 hydrate | BTA-EG4 hydrate | 921193-28-4 |
DPI-201-106 | SDZ-201 106 (+/-) | 97730-95-5 |
MCULE-3408819416 | SR31527 | 311814-78-5 |
AKOS037652256 | N1-(2-(4-(4-chloro-2-fluorophenyl)piperazin-1-yl)phenyl)-N4,N4-dimethylbenzene-1,4-disulfonamide | 2171065-77-1 |
SR 11302 | SSAA09E2 | 883944-52-3 |
PKZ18 | 849658-87-3 | |
1-adamantyl 4-[(2,5-dihydroxyphenyl)methylamino]benzoate | 化合物ADAPHOSTIN | 241127-58-2 |
MI-3 | MI-3 (Menin-MLL Inhibitor) | 1271738-59-0 |
Tradipitant | TRADIPITANT | 622370-35-8 |
SAR-405 | CS-2552 | 1523406-39-4 |
CS 2100 | CS-2100 | 913827-99-3 |
NSC370284 | NSC370284 | 116409-29-1 |
VL285 | VL285 | 1448188-57-5 |
LASVinhibitor3.3 | 化合物 LASV INHIBITOR 3.3 | 554438-52-7 |
FTY720(S)-Phosphate | (S)FTY720磷酸盐 | 402616-26-6 |
(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethyl bromomethyl ether | 罗拉匹坦(ROLAPITANT)中间体 | 530441-95-3 |
MLS 1547 | 5-CHLORO-7-[[4-(2-PYRIDINYL)-1-PIPERAZINYL]METHYL]-8-QUINOLINOL | 315698-36-3 |
MYLS22 | N-(1,5-二甲基-3-氧代-2-苯基-2,3-二氢-1H-吡唑-4-基)-3-甲基-1-苯基-1H-噻吩并[2,3-C]吡唑-5-甲酰胺 | 306959-01-3 |
SHIN1 | SHIN1 | 2146095-85-2 |
HyT36 | 化合物HYT36 | 1323151-45-6 |
superstat | (FREEBASE) | 90093-40-6 |
S-2-(4-Pyridyl)ethyl-L-cysteine | S-2-(4-吡啶基乙基)-L-半胱氨酸 | 28809-04-3 |
CYM5520 | 1-[2-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)-2-oxo-ethyl]-6-oxo-1,6-dihydro-pyridine-3-carbonitrile | 1449747-00-5 |
ML202 | 1221186-52-2 | |
4-CPPC | 4-CPPC | 29553-70-6 |
SEMBL | SEMBL | 1443448-82-5 |
Mesendogen | 化合物 T28020 | 864716-85-8 |
L-Arginine, N2-[[5-[bis(4-chlorophenyl)methyl]-3-methyl-2-thienyl]carbonyl]- | JR14a | 2411440-41-8 |
SB 224289A | 180084-26-8 | 180084-26-8 |
(2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol | 阿瑞洛莫 | 289893-25-0 |
NecroX-7 | NECROX-2 | 1120333-38-1 |
DB818 | DB-818 | 790241-43-9 |
SW-100 | SW-100 | 2126744-35-0 |
EVP4593 | N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 | 545380-34-5 |
Gingerenone A | 姜烯酮 A | 128700-97-0 |
UCF-101 | UCF-101 | 313649-08-0 |
DoPAT | 二硫代苯甲酸苄酯 | 27249-90-7 |
Benzamide | 1251957-89-7 | |
LEI110 | 化合物LEI110 | 2313525-90-3 |
DAC-2-25 | 化合物 T25284 | 1675245-09-6 |
M351-110 | ||
EC23 | 4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)ethynyl)-benzoicacid | 104561-41-3 |
SID 26681509 | SID26681509; SID-26681509 | 958772-66-2 |
CID 2745687 | CID 2745687 | 264233-05-8 |
ICA-105574 | 化合物ICA-105574 | 316146-57-3 |
KPT251 | SCHEMBL11318201; AOB6639; | 1388841-50-6 |
CPI 455 | 6-异丙基-7-氧代-5-苯基-4,7-二氢吡唑并[1,5-A]嘧啶-3-腈 | 1628208-23-0 |
MT 63-78 | 5-{2',6'-dihydroxy-[1,1'-biphenyl]-4-yl}-1H-indole-3-carbonitrile | 1179347-65-9 |
ASP 2905 | 化合物ASP-2905 | 792184-90-8 |
VK-28 | 5-[[4-(2-羟基乙基)-1-哌嗪基]甲基]-8-喹啉醇 | 312611-92-0 |
ML-SA5 | N'-[3-氯-2-(1-哌啶基)苯基]-N,N-二甲基-1,4-苯二磺酰胺 | 2418670-70-7 |
AGI-001 | S-吲哚洛尔 | 26328-11-0 |
NPY 5RA972 | N-[4-甲基-9-(1-甲基乙基)-9H-咔唑-3-基]-4-吗啉甲酰胺 | 439861-56-0 |
E1210(APX001A) | E 1210 (pharMaceutical) | 936339-60-5 |
JR-AB2-011 | 3-(3,4-dichlorophenyl)-1-(4-fluorophenyl)-1-(5-methyl-4,5-dihydro-1,3-thiazol-2-yl)urea | 329182-61-8 |
L82-G17 | L82G17 | 92285-87-5 |
ONO-1301 | 化合物 T28240 | 176391-41-6 |
FFN246 | (FREEBASE) | 2210244-83-8 |
M351-056 |
联系方式